Expired Tender Spain ICB TOT Ref. 23938811

Contract notice: General anti-infectives Tender in Spain - 23938811

Tender notice from Spain, published on 06 Jun 2018.

Executive Summary

The INSTITUT CATALÁ DE LA SALUT has issued a Tender notice for the procurement of a Contract notice: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents in the Spain. This Tender notice was published on 06 Jun 2018 and is scheduled to close on 20 Jun 2018, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 23938811, while the tender notice number is 241425-2018 and Register on the platform.

Key facts

Summary
Contract notice: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
TOT Ref. No.
23938811
Document Ref. No.
241425-2018
Country
Spain
Notice type
Tender
Competition
ICB
Publication date
06 Jun 2018
Bid deadline
20 Jun 2018
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Description: Contract notice: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: The most economic tender
CPV code: 33650000, 33650000
CPV Description: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents.
Aggregate supply of drugs: intravenous rituximab for patients who initiate treatment in the centers of the Catalan Institute of Health and the Catalan Institute of Oncology.
Reference Number: CS / CC00 / 1100715355/18 / AMUP
SS Aggregate drug supply: intravenous rituximab for patients startingtreatment in the centers of the Institut Catala de la Salut and Institut Catala d'Oncologia.
Aggregate supply of drugs: intravenous rituximab for patients who start treatment in the centers of the Catalan Institute of Health and the Catalan Institute of Oncology.
Internet address (URL): http://www.gencat.cat/ics/proveidors/index_htm
Directive: Classical Directive (2014/24/EU)

Documents

Tender Notice
Login to view

Similar tenders

Spain Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents was 20 Jun 2018. Bidding is closed.

This tender has been issued by INSTITUT CATALÁ DE LA SALUT in Spain.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 23938811. The purchaser document reference is 241425-2018.

See the Similar Tenders section on this page or browse other tenders from Spain.

This tender falls under Materials and Products in Spain. Suppliers in these sectors can track similar Spain tenders using CPV-based alerts.